Screener
Xeris Biopharma Holdings, Inc. XERS Gross Profit
Discontinued — last reported Q2 '26
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.
The source filing: Xeris Biopharma Holdings, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001867096-26-000065
FAQ
- What is Xeris Biopharma Holdings, Inc.'s gross profit?
- Xeris Biopharma Holdings, Inc. (XERS) reported gross profit of $79.59M in Q2 2026.
- How has Xeris Biopharma Holdings, Inc.'s gross profit changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s gross profit increased by 33.4% year-over-year, from $59.64M to $79.59M.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s gross profit?
- Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s gross profit has grown at a 61.9% compound annual growth rate (CAGR), from $36.27M to $249.28M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about Xeris Biopharma Holdings, Inc.'s gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude